ConductScience.org, home

Paper800384

A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.

Kiloh LG and 3 others. J Int Med Res, 1976. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients. Papers, record 800384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/800384

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
PubMed
Journal
J Int Med Res
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2017-02-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kiloh LGL G
2Williams SES E
3Grant DAD A
4Whetton PSP S

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DibenzoxazepinesMajor topic
LoxapineMajor topic
SchizophreniaMajor topic
TrifluoperazineMajor topic
Acute Disease
Adult
Chronic Disease
Clinical Trials as Topic
Double-Blind Method
Humans
Psychiatric Status Rating Scales

Source PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
25,859,275Revisiting loxapine: a systematic review.Ann Gen Psychiatry2015https://conductscience.org/library/papers/25859275PubMed
25,321,611Placebo response in antipsychotic clinical trials: a meta-analysis.JAMA Psychiatry2014https://conductscience.org/library/papers/25321611PubMed
17,943,763Loxapine for schizophrenia.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17943763PubMed
14,974,020Trifluoperazine for schizophrenia.Cochrane Database Syst Rev2004https://conductscience.org/library/papers/14974020PubMed
25,167Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.Drugs1978https://conductscience.org/library/papers/25167PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/800384

GET https://conductscience.org/api/papers/v1/800384/authors